Replimune Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	50.55	38.77	23.2	17.44	8.77	5.71	2.71
Research & Development	126.53	79.55	56.75	38.76	22.17	13.52	6.94
Operating Expenses	177.08	118.31	79.96	56.2	30.95	19.23	9.65
Operating Income	-177.08	-118.31	-79.96	-56.2	-30.95	-19.23	-9.65
Interest Expense / Income	4.16	2.22	3.06	1.92	0	0	0
Other Expense / Income	-7.24	-2.5	-2.15	-5.49	-0.11	0.47	-1.94
Pretax Income	-174	-118.04	-80.87	-52.63	-30.83	-19.7	-7.7
Income Tax	0.29	0	0	0	0	0	0
Net Income	-174.28	-118.04	-80.87	-52.63	-30.83	-19.7	-7.7
Shares Outstanding (Basic)	58	52	46	34	23	5	5
Shares Outstanding (Diluted)	58	52	46	34	23	5	5
Shares Change	11.49%	12.89%	34.99%	47.69%	365.97%	0.10%	-
EPS (Basic)	-2.99	-2.26	-1.75	-1.54	-1.33	-3.96	-1.55
EPS (Diluted)	-2.99	-2.26	-1.75	-1.54	-1.33	-3.96	-1.55
Free Cash Flow	-130.32	-84.52	-63.78	-67.09	-27.98	-16.15	-7.32
Free Cash Flow Per Share	-2.24	-1.62	-1.38	-1.96	-1.21	-3.24	-1.47
EBITDA	-167.39	-113.67	-76.1	-50.17	-30.69	-19.59	-7.58
Depreciation & Amortization	2.45	2.15	1.71	0.53	0.15	0.11	0.12
EBIT	-169.84	-115.81	-77.81	-50.71	-30.83	-19.7	-7.7

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).